Literature DB >> 11466029

The epidemiology of epilepsy: the size of the problem.

G S Bell1, J W Sander.   

Abstract

The prevalence of epilepsy is generally taken as between 5 and 10 cases per 1000 persons, and the overall incidence as about 50 cases per 100 000 persons. The rates are dependent on case ascertainment and on definitions used. The prognosis depends on many factors, including the number of seizures at presentation, the seizure type and the use of anti-epileptic drugs. Epilepsy carries an excess mortality; the cause of death can be unrelated to epilepsy, related to the underlying disease causing epilepsy, or related to epilepsy itself. Copyright 2001 BEA Trading Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11466029     DOI: 10.1053/seiz.2001.0584

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  26 in total

1.  Comparative performance evaluation of automated segmentation methods of hippocampus from magnetic resonance images of temporal lobe epilepsy patients.

Authors:  Mohammad-Parsa Hosseini; Mohammad-Reza Nazem-Zadeh; Dario Pompili; Kourosh Jafari-Khouzani; Kost Elisevich; Hamid Soltanian-Zadeh
Journal:  Med Phys       Date:  2016-01       Impact factor: 4.071

Review 2.  Epilepsy: A Spectrum Disorder.

Authors:  Joseph I Sirven
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-01       Impact factor: 6.915

3.  Identification of prevalent patients with epilepsy using administrative data: the Tuscany experience.

Authors:  Irene Bellini; Laura Policardo; Gaetano Zaccara; Pasquale Palumbo; Eleonora Rosati; Elena Torre; Paolo Francesconi
Journal:  Neurol Sci       Date:  2017-01-04       Impact factor: 3.307

4.  Seven-tesla susceptibility-weighted analysis of hippocampal venous structures: Application to magnetic-resonance-normal focal epilepsy.

Authors:  Rebecca Emily Feldman; Lara Vanessa Marcuse; Gaurav Verma; Stephanie Sian Gabriella Brown; Alexandru Rus; John Watson Rutland; Bradley Neil Delman; Priti Balchandani; Madeline Cara Fields
Journal:  Epilepsia       Date:  2020-02-04       Impact factor: 5.864

Review 5.  Chronic disorders with episodic manifestations: focus on epilepsy and migraine.

Authors:  Sheryl R Haut; Marcelo E Bigal; Richard B Lipton
Journal:  Lancet Neurol       Date:  2006-02       Impact factor: 44.182

6.  Epilepsy as a risk factor for cancer.

Authors:  C Adelöw; A Ahlbom; M Feychting; F Johnsson; J Schwartzbaum; T Tomson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-06       Impact factor: 10.154

7.  Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy.

Authors:  Joseph Gonzalez-Heydrich; Jane Whitney; Deborah Waber; Peter Forbes; Olivia Hsin; Stephen V Faraone; Alice Dodds; Sneha Rao; Christine Mrakotsky; Carlene Macmillan; David R Demaso; Carl de Moor; Alcy Torres; Blaise Bourgeois; Joseph Biederman
Journal:  Epilepsy Behav       Date:  2010-05-21       Impact factor: 2.937

Review 8.  PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases.

Authors:  Zhengxin Cai; Songye Li; David Matuskey; Nabeel Nabulsi; Yiyun Huang
Journal:  Neurosci Lett       Date:  2018-07-31       Impact factor: 3.046

9.  Effects of genistein on pentylenetetrazole-induced behavioral and neurochemical deficits in ovariectomized rats.

Authors:  Amr A Elsayed; Esther T Menze; Mariane G Tadros; Bassant M M Ibrahim; Nagwa A Sabri; Amani E Khalifa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-10-25       Impact factor: 3.000

10.  Training nurses in a competency framework to support adults with epilepsy and intellectual disability: the EpAID cluster RCT.

Authors:  Howard Ring; James Howlett; Mark Pennington; Christopher Smith; Marcus Redley; Caroline Murphy; Roxanne Hook; Adam Platt; Nakita Gilbert; Elizabeth Jones; Joanna Kelly; Angela Pullen; Adrian Mander; Cam Donaldson; Simon Rowe; James Wason; Fiona Irvine
Journal:  Health Technol Assess       Date:  2018-02       Impact factor: 4.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.